| 1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
| 2 |
Lu H, Zhang H, Wei Y, et al. Ambient mass spectrometry for molecular diagnosis of lung cancer[J]. Analyst, 2019, 145(2): 313-320.
|
| 3 |
Zhong Y, Gao T, Yuan X, et al. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression[J]. Cancer Biol Therapy, 2018, 19(5): 407-415.
|
| 4 |
刘蕾，魏素菊. KRAS突变的非小细胞肺癌的研究进展[J]. 中国肺癌杂志，2018, 21(5): 419-424.
|
| 5 |
侯宛昕，李和根，朱丽华. 中医药防治非小细胞肺癌术后复发转移概况[J]. 湖南中医杂志，2014, 30(4): 183-186.
|
| 6 |
Rangel D, Rojas , Irmgard , et al. Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species.[J]. J Molecul Med, 2018, 96(12): 1395-1405.
|
| 7 |
刘瑞清. 缺氧诱导因子-1α参与肝纤维化形成机制研究进展[J]. 实用肝脏病杂志，2021, 24(1): 145-148.
|
| 8 |
Khuc T, Hsu CWA, Sakamuru S, et al. Using β-lactamase and nanoLuc luciferase reporter gene assays to identify inhibitors of the HIF-1 signaling pathway[J]. Other, 2016, 1473: 23-31.
|
| 9 |
Lin MC, Lin JJ, Hsu CL, et al. GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness[J]. Oncogene, 2017, 36(30): 4243-4252.
|
| 10 |
Zhao Y, Wang XX, Wu W, et al. EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells[J]. Biochem Biophys Res Commun, 2019, 517(2): 201-209.
|
| 11 |
Hou P, Shi P, Jiang T, et al. DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer[J]. Br J Cancer, 2020, 122(5): 668-679.
|
| 12 |
赵志成，庄莉，贾长库，等. EGCG抑制肝癌细胞株HepG2增殖及HIF-1α/VEGF的表达[J]. 中国病理生理杂志，2010, 26(4): 713-720.
|
| 13 |
唐静，贾昱娴，农丽，等. MALAT-1和HIF-1α在三阴型乳腺癌中表达及临床意义[J]. 重庆医学，2019, 48(10): 28-31.
|
| 14 |
Wenming F, Tao X, Sanxiong H, et al. HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis[J]. Cell Molecul Biol Lett, 2018, 23(1): 26-36.
|
| 15 |
Lai HH, Li JN, Wang MY, et al. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis[J]. J Clin Invest, 2018, 128(2): 625-643.
|
| 16 |
焦言，杨文锋. 缺氧诱导因子-1与恶性肿瘤的相关性研究进展[J]. 中国实用医刊，2018, 45(15): 125-128.
|
| 17 |
马苑，付秀华，王立红. 肿瘤缺氧微环境的研究进展[J]. 癌症进展，2020, 18(2): 7-10+45.
|
| 18 |
Xu M, Zheng YL, Xie XY, et al. Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells[J]. DNA Cell Biol, 2014, 33(5): 275-281.
|
| 19 |
Zhang K, Han ES, Dellinger TH, et al. Cinnamon extract reduces VEGF expression via suppressing HIF-1α gene expression and inhibits tumor growth in mice[J]. Molecul Carcinogen, 2016, 56(2): 436-446.
|
| 20 |
Xiao H, Tong R, Ding C, et al. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition[J]. Oncotarget, 2015, 6(4): 2180-2192.
|
| 21 |
Sun QY, Ding LW, Johnson K, et al. SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells[J]. Oncogen, 2019, 38(34): 6196-6210.
|
| 22 |
Su X, Shen Z, Yang Q, et al. Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms[J]. Theranost, 2019, 9(15): 4461-4473.
|
| 23 |
Jiang XL, Gao JC, Jiang L, et al. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer][J]. Zhonghua Fu Chan Ke Za Zhi, 2019, 54(8): 541-547.
|
| 24 |
Costa RLB, Han HS, Gradishar WJ. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review[J]. Breast Cancer Res Treat, 2018, 169(3): 397-406.
|
| 25 |
Lin YT, Wang HC, Hsu YC, et al. Capsaicin induces autophagy and apoptosis in human nasopharyngeal carcinoma cells by downregulating the PI3K/AKT/mTOR pathway[J]. Int J Molecul Ences, 2017, 18(7): 1343-1355.
|
| 26 |
Dong P, Hao F, Dai S, et al. Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways[J]. J Recept Sign Transd, 2018, 38(1): 83-88.
|